The Innovation and Technology Tariff (ITT) aims to incentivize adoption of transformative innovations in the NHS by streamlining pricing and reimbursement. For 2017-19, the first year of the ITT, six themes have been identified that could provide innovation benefits to the NHS at scale. These themes include guided mediolateral episiotomy to minimize obstetric injuries, reducing medication errors, preventing ventilator-associated pneumonia, managing COPD remotely, treating C. difficile infection with frozen fecal transplants, and treating enlarged prostates as outpatients. The ITT operates under both an incentive-based pricing model and a zero-cost model where NHS England covers the cost of approved innovations.

1. ITT was introduced to incentivise the adoption and spread of transformational
innovation in the NHS. It aims to remove the need for multiple local price
negotiations and guarantee automatic reimbursement when an approved
innovation is used. At the same time the ITT allows NHS England to optimise its
purchasing power and negotiate national “bulk buy” price discounts where
applicable on behalf of the NHS.
For 2017-19 as the first year of the ITT this is a pathfinder year and 6 themes
have been identified which could provide innovation benefits to the NHS at
scale.
Guidance available here:-
https://www.england.nhs.uk/resources/pay-syst/development/tech-tariff-17-19-
technical-notes
Or use Bitlly link:- bit.ly/NHS_ITT
Accessing the zero cost NHS Innovation and Technology Tariff
2017-18

2. The Innovation and Technology Tariff (ITT)
Theme Example product How will it operate
1) Guided mediolateral episiotomy to minimise
the risk of obstetric anal sphincter injury
Episcissors-60 Incentive based on activity. The price 16.00 per
use.
2) Reduction of bacterial contamination and
accidental administration of medication
Non-injectable arterial
connector (NIC)
Provided under the zero cost model. The value of
this device per patient is £2.
3) Prevention of ventilated associated
pneumonia in critically ill patients
Pnuex Provided under the zero cost model. NHS England
is covering the cost of the tubes valued at £150
each.
4) Applications for the self-management of
Chronic Obstructive Pulmonary Disease
myCOPD Provided under the zero cost model. NHS England
is covering the cost of licences valued at £20.00
per patient.
5) Frozen Faecal microbiota transplantation
(FMT) for recurrent Clostridium difficile
infection rates
Frozen Faecal Microbiota
Transplants for Chronic
C.difficile Infections
Provided under the zero cost model. NHS England
is covering the cost of FMT aliquots valued at
£95.00 per patient.
6) Management of Benign prostatic hyperplasia
as a day case
Urolift Re-imbursement automated via tariff recoded
under a new OPCS code.
In parallel, but separately from the ITT, NHS England is centrally funding a 7th theme “Identification and
measurement of atrial fibrillation through mobile ECG technology”. Further information on this programme of
work will be published in due course.

3. ITT Zero Cost Model
Themes “Guided mediolateral episiotomy to minimise the risk of obstetric anal sphincter
injury” and “The Management of Benign prostatic hyperplasia as a day case” operate under
separate arrangements.

4. For further information and queries relating to the ITT please contact the NHS
England Innovation and Research Unit here england.innovation@nhs.net
Reporting
Providers and commissioners implementing ITT themes are required to complete
a minimum data sets for each one.
• For 5 of the 6 themes require the completion of a Minimum Data Set to NHS
via Arden Gem CSU
• Themes 1, 3, 4 and 5 will be captured via an excel report template provided
by Arden and Gem CSU. Theme 2 will require follow up evaluation with trusts
who take up the innovation at the end of the first year.
• Theme 6:- Prostatic urethral lift systems to treat benign prostatic hyperplasia
is covered by National Tariff. Data about use of the procedure will be
collected through National Tariff audit processes and specific data reporting
requirements are not included in the ITT.

5. NHS Innovation and Technology Payment 2018/19
What is it?
• The Innovation and Technology Payment (ITP) builds on the Innovation and Technology
Tariff (ITT) and aims to support the NHS in adopting innovation by removing financial or
procurement barriers to uptake of innovative products or technologies.
• It is a competitive process to identify innovations and technologies that will offer the
greatest quality and efficiency benefits with wider adoption.
• The ITP is looking to support medical devices, digital platforms and technologies. The
programme is not suitable for pharmaceutical products or research projects.
• Applicants can be from any of the following healthcare, academia, and the commercial
or voluntary sectors.
• The ITP application process will identify themes into which one or more innovations
may fit.
• The implementation of any agreed payment mechanism or procurement will be
operational from April 2018.

6. Making an application
What are we looking for?
• Applicants should show that their proposed innovation or technology is cost effective
and addresses a clearly identified need or problem. The case must be convincing: the
innovation should focus on resolving a particular problem, either by giving a health and
wellbeing or quality gain or by delivering the same quality at a lower cost.
• Applications will need to include robust evidence to demonstrate that their innovation
is genuinely high impact, affordable and at the correct level of maturity and relevance
for widespread diffusion.
• Applicants are required to detail the existing evidence that supports wider uptake of
their innovation in the NHS and the likely efficiencies that could be realised as a result
of this.
• The ITP will be suitable for innovations which are market ready and have been tested in
the NHS, but which could achieve greater scale and use with central support to
overcome the barriers to wider adoption.
• Applicants will therefore need to describe efforts that have been made to widen
adoption of their innovation in the NHS and the barriers that they and NHS
organisations have encountered.

7. Making an application
Application timeline
Activity Date
Open for registrations of interest 14 June 2017
Open for applications 17 July 2017
Final application deadline 8th September 2017 (12:00 noon)
Screening September 2017
Application sifting round 1 October 2017
Application sifting round 2 November 2017
Decision panel select final cohort December 2017
Outcomes communicated to applicants December 2017
Definition of ITP theme agreed January 2018
Strategic planning period January - March 2018
Scheme launched April 2018

8. Making an application
• Selection criteria will focus on the strategic fit of the innovation with NHS England
priorities, the contribution to the efficiency challenge, the evidence base for the
innovation and the feasibility of implementing change via the ITP.
• An understanding of current NHS England priorities can be reached by reading the Next
Steps on the Five Year Forward View document (available at
https://www.england.nhs.uk/publication/next-steps-on-the-nhs-five-year-forward-
view/) or the current NHS England business plan (available at
https://www.england.nhs.uk/publications/business-plan/).
• We welcome applications from people working either nationally or internationally in
healthcare commissioning and provision, academia, industry and the voluntary sector.
• The deadline for applications is noon on 8 September 2017. Applicants should read the
Call for Applications and Guidance Notes in full before completing an application.
• Further information available here:- http://www.innovation.england.nhs.uk/itp